Recordati Confirms CVC’s Non-Binding Interest in Potential Takeover Bid

Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has issued an announcement.

Recordati disclosed that it has received a non-binding expression of interest from private equity firm CVC for a potential voluntary full takeover bid intended to delist the company from the stock exchange. The proposal, which includes an indicative price of €52.00 per share and is subject to due diligence, financing and partner identification, has not yet been evaluated by Recordati’s corporate bodies, leaving the potential impact on ownership structure and future strategy uncertain for shareholders and other stakeholders.

The most recent analyst rating on (IT:REC) stock is a Buy with a EUR57.50 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.

More about Recordati Industria Chimica e Farmaceutica SPA

Recordati Industria Chimica e Farmaceutica is an international pharmaceutical group listed on Borsa Italiana, originating from a family-run pharmacy in Northern Italy in the 1920s. The company offers therapies in both general and specialist medicine as well as for rare diseases, operating in an integrated model from clinical development to production, marketing and licensing of APIs and finished drugs across about 150 countries in EMEA, the Americas and APAC.

Average Trading Volume: 337,932

Technical Sentiment Signal: Buy

Current Market Cap: €9.55B

Learn more about REC stock on TipRanks’ Stock Analysis page.